Loading...
•
Mar 31, 2024
The Joint Q1 2024 Earnings Report
The Joint Corp. grew revenue and improved bottom-line year-over-year.
Key Takeaways
The Joint Corp. reported a 5% increase in revenue to $29.7 million and operating income of $1.1 million. Net income was $947,000, compared to $2.3 million in the previous year, which included a $3.9 million employee retention credit. System-wide sales increased by 9% to $126.3 million, and system-wide comp sales grew by 3%.
Revenue grew by 5% to $29.7 million.
Operating income was $1.1 million, compared to an operating loss of $653,000.
Net income was $947,000, compared to $2.3 million, which included a $3.9 million employee retention credit in the prior year.
System-wide sales increased by 9% to $126.3 million.
Forward Guidance
The company reiterated all elements of its guidance.
Positive Outlook
- 2024 System-wide sales are expected to be between $530 and $545 million dollars, compared to $488.0 million dollars in 2023.
- System-wide comp sales for all clinics open 13 months or more are expected to be in the mid-single digits in 2024.
- 2024 new franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 60 and 75, compared to 104 in 2023.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...